NuvOx Announces Positive Results 1st Cohort Phase Ib Trial
Tucson, AZ – 11/06/2025 - NuvOx Therapeutics, Inc. (“NuvOx”) Announces Positive Results from First Cohort of EXTEND-1b Trial of NanO₂™ in Patients with Respiratory Distress NuvOx Therapeutics (“NuvOx”), a clinical-stage biotechnology company developing oxygen...
Tech Parks Arizona Economic Impact
11/06/2025 - Desert Angels infrastructure partner Tech Parks Arizona announces its economic impact report for 2024. Big News!? Following 30 years of growth and innovation, Tech Parks Arizona continues to be one of the region’s most powerful economic engines. A newly...
Delta Development Team Exceeds New Prehospital Blood Transfusion Standards
11/03/2025 - DDT Exceeds New Prehospital Blood Transfusion Standards & Guidelines for EMS with its APRU 6L and Delta ICE 2L Stop adapting. Start trusting what’s proven. Every mission begins with good intentions. You adapt, improvise, and make do with what you have...
Clinical Trial Confirms GammaTile Superior Tumor Control
TEMPE, Ariz., Oct. 21, 2025 /PRNewswire/ GT Medical Technologies, a company focused on improving the lives of patients with brain tumors, today announced the interim results from its ROADS clinical trial (Randomized Controlled Trial of Resection [Surgery] and...
2025 Brutal Biotech Investment Climate
Tucson, AZ – August 20, 2025 - Questex Fierce Biotech - shared by Reglagene, Inc. The first half of 2025 was brutal for biotech, but investors remain keen on therapeutics in several indications, and silver linings exist, particularly for private companies. “You’ve got...
Delta Development Team – Introducing BloodCOMM Premium
09/05/2025 - Introducing BloodCOMM Premium Built for organizations that demand the highest level of insight and control across the blood cold chain, BloodCOMM Premium delivers a new standard in blood management technology. Full-Service, Cloud-Based Platform Designed...
Special Operations Forces Blood Cooler from Delta Development
09/03/2025 Delta Ice 2L debut at New Castle Blood Symposium Built for Special Operations Forces, this 1L blood cooler sets a new standard for mission readiness: Rugged military design for the harshest environments 96-hour holdover at 110°F while maintaining up to 6°C...
UACI startup alumni Reglagene making impressive strides in brain cancer treatment
UACI Alumni Reglagene Advances Brain Cancer TreatmentUACI startup alumni Reglagene is making impressive strides in brain cancer treatment research. Based on research from the University of Arizona and launched through Tech Launch Arizona, Reglagene is gaining...